The Supreme Court on Thursday made it clear that the trial does not abate and neither does it result in order of acquittal of the accused public servant if the complainant turns 'hostile' or has died or is unavailable to let in his evidence during proceedings.
Delhi Lieutenant Governor VK Saxena on Thursday approved the proposal of the Delhi Police to appoint special public prosecutors to represent the Union Territory in the trial court in the Shraddha Walkar murder case.
The Rouse Avenue Court of Delhi on Thursday took cognisance on a chargesheet filed by the Central Bureau of Investigation (CBI) against Vijay Nair and Abhishek Boinpally, two public servants and others named in the chargesheet filed in connection with the Delhi liquor policy case.
The memorandum also demanded Pakistan desist, overtly or covertly, from engaging with those forces that stood against our freedom struggle. It also expects Pakistan to offer an unconditional apology to our Honorable Prime Minister and beloved leader Sheikh Hasina and to the people of Banglad
There was no difference in cognitive function after either of the interventions in a big trial that examined whether exercise and mindfulness training may improve cognitive function in older persons.
Convict Kiran Kumar sought this interim order pending disposal of the criminal appeal filed earlier by him challenging the sentence delivered by the trial court in May. He also sought to release him on bail.
A randomised clinical trial has found that treating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery.
The Supreme Court on Monday asked the trial court to indicate how much time is likely to be needed to conclude the trial in the Lakhimpur violence case against Ashish Mishra.
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results